Sebastian Krawiec

Susan Kleiner, PhD, discusses gaps in creatine research for women, from menstrual cycle control to lower baseline stores and variable performance benefits.

Susan Kleiner, PhD, explains how creatine may support women through hormonal transitions, aiding mood, cognition, strength, and recovery.

The scheduling does not apply to botanical kratom, but rather synthetically derived 7-hydroxymitagynine (7-OH), MP, MGM-15, and MGM-16, which the plant contains in small amounts.

Susan Kleiner, PhD, explains how evidence favors creatine monohydrate, while newer forms lack superior outcomes; major gaps remain in data for children, gummies, fertility, and pregnancy.

Ahead of IFT First, Lauretta Katsriku, global category leader for collagen, at Rousselot walks through new clinical findings on the company's Nextida GC collagen peptide and explains why pairing collagen with whey protein could help brands navigate a tight supply and rising costs.

Ashish Talati discusses the proposed GRAS rule, and what industry needs to understand about complying with the rule should it be finalized.

President Trump announced in a Truth Social post that he will be nominating Heidi Overton, MD, PhD, as FDA's new Commissioner to replace Commissioner Martin Makary who resigned in May.

Joey Savage, Founder of Savage Nutrition, previews his talk on mitochondrial health and longevity ahead of The Outlook on Active Nutrition.

Ben Kane, president of PricePlow, previews his discussion at The Outlook on Active Nutrition, exploring where regulation, innovation, and industry trends collide.

Founder Joey Savage and partnerships director Ben Kane discuss educational sessions, product testing, and industry innovation ahead of the September event.